Venoocclusive disease of the liver following bone marrow transplantation

Transplantation
R J JonesR Saral

Abstract

Review of 235 consecutive patients undergoing bone marrow transplantation was performed in order to define the clinical syndrome of venoocclusive disease of the liver (VOD) in these patients. Analysis of all patients with histologically proven VOD revealed a consistent clinical syndrome of liver dysfunction occurring within the first 3 weeks after marrow infusion. This was characterized by hyperbilirubinemia peaking at greater than or equal to 2 mg/dl with at least 2 of 3 other findings: hepatomegaly, ascites, and 5% or greater weight gain. VOD developed in 22% (52 of 235). A persistently elevated aspartate aminotransferase (SGOT) prior to transplant was associated with an increased risk of developing VOD by multivariate analysis (P = 0.0003), and acute leukemia in first remission was associated with a decreased risk (P = 0.02). Neither the preparative regimen (busulfan and cyclophosphamide versus cyclophosphamide and total body irradiation) nor the type of graft (allogeneic versus autologous) influenced the occurrence. Twenty-four of these 52 patients (47%) died with VOD (10% of the entire group). This makes VOD the third leading cause of death in our allogeneic graft recipients, and the second leading cause in our patients re...Continue Reading

Citations

May 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S I StrasserG B McDonald
May 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L D DeLeveG C Kanel
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·L EmbreeJ H Goldie
Oct 19, 1999·Medical Oncology·M Hassan
Jan 31, 2012·European Journal of Clinical Pharmacology·Janka ReimerChristoph A Ritter
Nov 24, 2006·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Geneviève BenoitAicha Merouani
Jan 18, 2003·Current Gastroenterology Reports·Laurie D DeLeve
Jun 1, 2008·Hepatology International·George K K Lau
Oct 8, 2008·International Journal of Hematology·Athanasios PapadopoulosApostolos Hatzitolios
Aug 1, 1995·Journal of Pharmaceutical and Biomedical Analysis·R B BurnsL Embree
Mar 19, 2003·Blood Reviews·Jason A CoppellDavid J Perry
Aug 7, 1999·Journal of Chromatography. B, Biomedical Sciences and Applications·J E PerisF Torres-Molina
Sep 24, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Il-Deok KimKoichi Tanaka
Apr 5, 2011·Bone Marrow Transplantation·E Carreras, M Diaz-Ricart
Aug 26, 2006·Nature Clinical Practice. Nephrology·Norbert LameireRaymond Vanholder
May 31, 2001·British Journal of Haematology·C LiatsosA K Burroughs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.